Akoustis Technologies Inc expected to post a loss of 11 cents a share - Earnings Preview

Aktis Oncology

02/09/2024 13:54

* Akoustis Technologies Inc  AKTS.OQ   AKTS.O  is expected
to show
a fall in quarterly revenue when it reports  results on
September 4 (estimated) for the period ending June 30 2024
    * The Huntersville North Carolina-based  company is expected
to
report a 12.1% decrease in revenue to $7.323 million from $8.33
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Akoustis Technologies
Inc is
for a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $1.00​, above​ its last closing price
of $0.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.14       -0.12      -0.14     Missed  -16.7
 Dec. 31 2024  -0.19       -0.18      -0.19     Missed  -5.6
 Sep. 30 2023  -0.18       -0.18      -0.26     Missed  -44.4​
 Jun. 30 2023  -0.16       -0.17      -0.21     Missed  -26.5
 ​​Jan.        -0.20       -0.19      -0.20     Missed  -4.2
 1 0001                                                 
 Dec. 31 2022  -0.25       -0.25      -0.19     Beat    24​
 Sep. 30 2022  -0.22       -0.20      -0.28     Missed  -38.3
 Jan. 1 0001               -0.19      -0.26     Missed  -34.5
 This summary was machine generated September 2 at 12:54 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)